Results 81 to 90 of about 5,375 (154)

Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes. [PDF]

open access: yesBlood Cancer J
Zeidan AM   +20 more
europepmc   +1 more source

SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites. [PDF]

open access: yesJ Clin Transl Hepatol, 2021
Gao Y, Wei L, Zhang DD, Chen Y, Hou B.
europepmc   +1 more source

Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS. [PDF]

open access: yesBlood Cancer J
Komrokji RS   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy